Merck Animal Health Signed a Definitive Agreement to Acquire Vence
Shots:
- Merck Animal Health to acquire Vence from its founders and shareholders & the transaction is expected to be completed in Q3’22
- Vence provides virtual fencing technology for rotational grazing and livestock management. The technology also allows the cattle producers and ranchers to manage natural resources more effectively
- The acquisition will broaden Merck Animal Health’s portfolio of veterinary pharmaceuticals, vaccines, and animal intelligence solutions to advance animal health and well-being along with customers’ outcomes. Additionally, the technology is currently available in the US and parts of Australia
Ref: Businesswire | Image: Merck Animal Health
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
